thiotepa has been researched along with Atypical Endometrial Hyperplasia in 1 studies
Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).
Atypical Endometrial Hyperplasia: A benign form of endometrial hyperplasia with increased number of cells with atypia. The atypical cells are large and irregular and have an increased nuclear/cytoplasmic ratio. The risk of progression to endometrial carcinoma rises with the increasing degree of cell atypia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Livshits, MA | 1 |
| Tsyrlina, EV | 1 |
1 review available for thiotepa and Atypical Endometrial Hyperplasia
| Article | Year |
|---|---|
[Hormones in the pathogenesis and treatment of malignant ovarian tumors].
Topics: Adrenal Cortex Hormones; Androgens; Animals; Clinical Trials as Topic; Drug Evaluation; Drug Therapy | 1977 |
1 trial available for thiotepa and Atypical Endometrial Hyperplasia
| Article | Year |
|---|---|
[Hormones in the pathogenesis and treatment of malignant ovarian tumors].
Topics: Adrenal Cortex Hormones; Androgens; Animals; Clinical Trials as Topic; Drug Evaluation; Drug Therapy | 1977 |